pmc logo image
Statistical issues in toxicokinetic modeling: a bayesian perspective.
P Bernillon and F Y Bois
Environ Health Perspect. 2000 October; 108 Suppl 5: 883–893.
 Is Cited by the Following Articles in this Archive:
Population Toxicokinetic Modeling of Cadmium for Health Risk Assessment
Billy Amzal, Bettina Julin, Marie Vahter, Alicja Wolk, Gunnar Johanson, and Agneta Åkesson
Environ Health Perspect. 2009 August; 117(8): 1293–1301. Published online 2009 May 6. doi: 10.1289/ehp.0800317.
PMCID: PMC2721875
Computational Toxicology of Chloroform: Reverse Dosimetry Using Bayesian Inference, Markov Chain Monte Carlo Simulation, and Human Biomonitoring Data
Michael A. Lyons, Raymond S.H. Yang, Arthur N. Mayeno, and Brad Reisfeld
Environ Health Perspect. 2008 August; 116(8): 1040–1046. Published online 2008 April 26. doi: 10.1289/ehp.11079.
PMCID: PMC2516557
Issues in the Pharmacokinetics of Trichloroethylene and Its Metabolites
Weihsueh A. Chiu, Miles S. Okino, John C. Lipscomb, and Marina V. Evans
Environ Health Perspect. 2006 September; 114(9): 1450–1456. Published online 2006 May 9. doi: 10.1289/ehp.8691.
PMCID: PMC1570093
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of drugs – method development and application to magnesium in sheep
Richard N Upton and Guy L Ludbrook
BMC Pharmacol. 2005; 5: 5. Published online 2005 March 10. doi: 10.1186/1471-2210-5-5.
PMCID: PMC555767